Canada markets closed

Epigenomics AG (EPGNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.35000.0000 (0.00%)
At close: 03:17PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
6,221
6,203
842
1,125
1,533
Cost of Revenue
145
136
145
253
440
Gross Profit
6,076
6,067
697
872
1,093
Operating Expenses
Research Development
4,706
3,111
3,659
7,340
6,418
Selling General and Administrative
4,994
4,437
3,467
4,523
4,176
Total Operating Expenses
12,678
10,229
10,811
15,974
14,385
Operating Income or Loss
-6,602
-4,162
-10,114
-15,102
-13,292
Interest Expense
71
52
55
63
550
Income Before Tax
-2,845
-2,410
-11,663
-14,566
-13,430
Income Tax Expense
12
18
23
2,454
-738
Income from Continuing Operations
-2,857
-2,428
-11,686
-17,020
-12,692
Net Income
-2,857
-2,428
-11,686
-17,020
-12,692
Net Income available to common shareholders
-2,857
-2,428
-11,686
-17,020
-12,692
Basic EPS
-
-0.22
-1.98
-3.61
-3.59
Diluted EPS
-
-0.22
-1.98
-3.61
-3.59
Basic Average Shares
-
11,207
5,892
4,751
3,538
Diluted Average Shares
-
11,207
5,892
4,751
3,538
EBITDA
-
-1,939
-11,073
-13,990
-12,572